Latest News
Featured News
FDA clears global Phase III trial for iSCIB1+
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
Scancell Appoints Dr Nermeen Varawalla as Chief Medical Officer
Scancell Provides Update from iSCIB1+ Clinical Advisory Meeting to Strengthen Plans for Phase 2/3 Registration Clinical Trial
Appointment of Dr Florian Reinaud to Scancell Board of Directors
Scancell extends Convertible Loan Note redemption dates by a further two years
Block Listing Return and Total Voting Rights
Change of Nominated Advisor
It is with great sadness that Scancell announces the death of former Chairman John Chiplin
Scancell founder says the company is ready to commercialise novel medicines to counteract cancer
Scancell Signs Agreement with Major International Biotechnology Company to Evaluate an Antibody in the Glymab® Portfolio
21st Association for Cancer Immunotherapy (CIMT) Annual Meeting, Mainz, May 2024
Scancell receives MHRA approval to expand ModiFY trial
Scancell to present at the 2024 ASCO Annual Meeting
No results found.
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.